Primary Endpoint and Analysis Model for Prevention Trials with Participants with Preclinical AD: Lessons Learned from the DIAN‐TU Platform Trial

Our experience from the DIAN-TU platform trial suggests that time-to-recurrent-event is a more effective endpoint for preclinical AD trials. Survival analysis provides more tangible and clinically relevant insights by translating treatment effects into reductions in hazard rates or extended survival times.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70859_099564
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Primary Endpoint and Analysis Model for Prevention Trials with Participants with Preclinical AD: Lessons Learned from the DIAN‐TU Platform Trial

Guoqiao Wang, Yan Li
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Primary Endpoint and Analysis Model for Prevention Trials with Participants with Preclinical AD: Lessons Learned from the DIAN‐TU Platform Trial

Guoqiao Wang, Yan Li
article en

Abstract

Our experience from the DIAN-TU platform trial suggests that time-to-recurrent-event is a more effective endpoint for preclinical AD trials. Survival analysis provides more tangible and clinically relevant insights by translating treatment effects into reductions in hazard rates or extended survival times.

Alzheimer s & DementiaVol. 21(S5)
Washington University in St. Louis (US)
Good health and well-being
Openalex Percentile: Top 33%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Primary Endpoint and Analysis Model for Prevention Trials with Participants with Preclinical AD: Lessons Learned from the DIAN‐TU Platform Trial — Guoqiao Wang, Yan Li · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS